Skip to main content
Equibles

Legal & General Group Plc

Position in LGND — Ligand Pharmaceuticals Inc

CIK 764068 London, X0
Back to LGND Full portfolio

Position in LGND

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$31,212,622
+$11,714,804 QoQ
Shares Held
98,746
+1.1% QoQ
Ownership
0.495%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#47
of 415 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. LGND ranks #11 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,870,015 $928,892,550
2 REGN
Regeneron Pharmaceuticals, Inc.
 759,971 $473,872,316
3 ALNY
Alnylam Pharmaceuticals, Inc.
 924,561 $278,320,596
4 RPRX
Royalty Pharma plc
 3,800,504 $213,094,258
5 INCY
Incyte Corp
 1,605,980 $182,053,892
6 ARGX
Argenx SE
 177,164 $164,367,443
7 INSM
INSMED Inc
 826,431 $88,114,072
8 RVMD
Revolution Medicines, Inc.
 381,366 $71,422,223

All Filings in LGND

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $31,212,622 98,746
2026-03-31 $19,497,818 97,660
2025-12-31 $20,491,972 108,383
2025-09-30 $19,196,660 108,370
2025-06-30 $13,452,094 118,333
2025-03-31 $10,741,311 102,162
2024-12-31 $6,197,340 57,838
2024-09-30 $5,522,964 55,180
2024-06-30 $3,971,594 47,135
2024-03-31 $3,481,167 47,622
2023-12-31 $3,390,592 47,474
2023-09-30 $2,732,651 45,605
2023-06-30 $3,407,229 47,257
2023-03-31 $3,419,215 46,482
2022-12-31 $3,121,697 46,732
2022-09-30 $3,934,105 45,687
2022-06-30 $4,326,720 48,495
2022-03-31 $5,238,098 46,565
2021-12-31 $7,259,153 46,997
2021-09-30 $6,345,604 45,547
2021-06-30 $3,506,969 26,732
2021-03-31 $4,730,062 31,027
2020-12-31 $2,262,784 22,753
2020-09-30 $2,179,395 22,864
2020-06-30 $2,502,865 22,377
2020-03-31 $1,534,026 21,095